Rocket Lab Eyeing Semiconductors Expansion – Inks Initial Pact Worth $23.9M For CHIPS Act Funding
Rocket Lab secures $23.9M CHIPS Act funding to expand semiconductor production for critical space missions.
Curaleaf International Is Beating Illicit Cannabis Prices In UK And Germany – What’s Next For EU Expansion?
Curaleaf International (OTC: CURLF), a leading cannabis company, is expanding its footprint across the UK, Germany and Poland. This strategic expansion is not only about entering new markets but also about outpricing the illegal cannabis trade. What drives their decision to enter specific markets?
FDA Fast-Tracks Ipsen And Genfit’s New Liver Disease Treatment, Iqirvo
The U.S. FDA has granted accelerated approval for Iqirvo, a novel drug from Ipsen SA and Genfit SA, designed for treating primary biliary cholangitis (PBC). This approval, based on the drug's ability to reduce alkaline phosphatase levels, marks a significant advancement in therapies available for PBC.
Why Is QuantaSing Stock Gaining Today?
QuantaSing sees shares surge premarket as it launches a $20M share repurchase program, signaling confidence in its growth trajectory.
Charles River Laboratories In Collaboration With MatTek Awarded $1.3M Grant From The Foundation For Chemistry Research And Initiatives To Advance Research Alternatives
Project will utilize an integrated approach to develop an in vitro alternative to inhalation toxicology studiesCharles River Laboratories International, Inc. (NYSE:CRL) today announced a multidisciplinary program, funded
Annovis Bio’s Recent Phase II/III Alzheimer’s Study Of Buntanetap, Showed Statistically Significant Efficacy And Safety In Both Carriers And Non-Carriers Of Apolipoprotein E4, A Genetic Cause Of AD
Annovis Bio Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's disease (PD), today
Biora Therapeutics To Present On The BioJet Systemic Oral Delivery Platform At The Next Gen Peptide Formulation & Delivery Summit 2024
Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present preclinical data from the BioJet™ Systemic Oral Delivery Platform at the
BNY: Bank Of New York Mellon Embraces New Name After 240 Years
Bank of New York Mellon (NYSE:BK) is rebranding to BNY, CEO Robin Vince announced in a memo to…
Toyota’s Certification Crisis Extends Beyond Japan, Could Impact EU Operations
Toyota Motor Corp. faces severe implications worldwide after discrepancies in vehicle certifications breach United Nations standards, impacting operations across 62 countries including the EU.
General Motors Reveals $6B Stock Buyback – What’s Going On?
General Motors announces a $6 billion share repurchase plan, aiming to boost shareholder value amidst positive financial performance.